Fredun Pharmaceuticals Limited Share Price
Fredun Pharmaceuticals Limited Share Price Today
As of 5 Jul 2026, Fredun Pharmaceuticals Limited share price is ₹2,588.80. The stock opened at ₹2,719.20, compared to its previous close of ₹2,758.80. During today's trading session, Fredun Pharmaceuticals Limited share price moved in the range of ₹2,552.05 to ₹2,781.00, with an average price of ₹2,666.53 for the day. Looking at its last 52-week, the stock has touched a low of ₹794.00 and a high of ₹2,891.00.
Fredun Pharmaceuticals Limited Returns Calculator
Fredun Pharmaceuticals Limited Shareholder Returns
Fredun Pharmaceuticals Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Fredun Pharmaceuticals Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | ₹635.47 | ₹453.82 |
| Other Income | ₹3.66 | ₹2.45 |
| Total Revenue | ₹639.12 | ₹456.27 |
| Total Expenses | ₹592.13 | ₹428.78 |
| Profit Before Tax | ₹47.00 | ₹27.49 |
| Tax | ₹14.38 | ₹7.75 |
| Profit After Tax | ₹32.62 | ₹19.74 |
| EPS - Basic | ₹66.81 | ₹41.78 |
| EPS - Diluted | ₹61.23 | ₹42.53 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Profit before tax | ₹32.62 | ₹20.03 |
| Income before WC changes | ₹80.84 | ₹55.09 |
| Change in Assets | -₹28.56 | -₹169.59 |
| Change in Liabilities | -₹39.37 | ₹97.91 |
| Change in WC | -₹67.93 | -₹71.68 |
| Cash flow from Operations | ₹11.90 | -₹16.60 |
| Cash flow from Investing | -₹73.59 | -₹6.35 |
| Cash flow from Financing | ₹121.45 | ₹26.65 |
| Total Cash Flow | ₹59.76 | ₹3.70 |
| Cash (Start of the year) | ₹5.22 | ₹1.52 |
| Cash (End of the year) | ₹64.98 | ₹5.22 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Non-Current Assets | ₹143.91 | ₹60.21 |
| Current Assets | ₹498.17 | ₹427.20 |
| Total Assets | ₹642.08 | ₹487.41 |
| Current Liabilities | ₹296.86 | ₹328.10 |
| Net Current Asset | ₹201.31 | ₹99.11 |
| Non-Current Liabilities | ₹67.11 | ₹17.93 |
| Equity Capital | ₹278.11 | ₹141.38 |
| Total Equity & Liabilities | ₹642.08 | ₹487.41 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹635.47 | ₹453.82 | ₹348.16 | ₹274.68 |
| Other Income | ₹3.66 | ₹2.45 | ₹0.92 | ₹1.82 |
| Total Revenue | ₹639.12 | ₹456.27 | ₹349.07 | ₹276.50 |
| Total Expenses | ₹591.54 | ₹428.00 | ₹327.62 | ₹258.99 |
| Profit Before Tax | ₹47.58 | ₹28.27 | ₹21.45 | ₹17.51 |
| Tax | ₹14.38 | ₹7.46 | ₹5.83 | ₹6.70 |
| Profit After Tax | ₹33.21 | ₹20.81 | ₹15.62 | ₹10.81 |
| EPS - Basic | ₹68.01 | ₹44.83 | ₹33.81 | ₹24.13 |
| EPS - Diluted | ₹62.33 | ₹44.37 | ₹33.47 | ₹22.93 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹33.21 | ₹20.81 | ₹15.62 | ₹10.76 |
| Income before WC changes | ₹81.10 | ₹55.27 | ₹38.22 | ₹29.16 |
| Change in Assets | -₹25.15 | -₹174.13 | -₹54.39 | -₹62.33 |
| Change in Liabilities | -₹39.93 | ₹96.41 | ₹15.73 | ₹18.76 |
| Change in WC | -₹65.08 | -₹77.72 | -₹38.66 | -₹43.57 |
| Cash flow from Operations | ₹16.44 | -₹20.98 | -₹0.44 | -₹14.41 |
| Cash flow from Investing | -₹73.58 | -₹5.99 | -₹7.64 | -₹9.40 |
| Cash flow from Financing | ₹121.82 | ₹25.90 | ₹5.99 | ₹25.18 |
| Total Cash Flow | ₹64.67 | -₹1.07 | -₹2.08 | ₹1.36 |
| Cash (Start of the year) | ₹0.28 | ₹1.35 | ₹3.44 | ₹2.07 |
| Cash (End of the year) | ₹64.95 | ₹0.28 | ₹1.35 | ₹3.44 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹143.89 | ₹64.40 | ₹50.46 | ₹41.07 |
| Current Assets | ₹498.24 | ₹422.25 | ₹257.14 | ₹216.21 |
| Total Assets | ₹642.14 | ₹486.65 | ₹307.60 | ₹257.28 |
| Current Liabilities | ₹296.31 | ₹327.32 | ₹166.83 | ₹139.66 |
| Net Current Asset | ₹201.93 | ₹94.93 | ₹90.31 | ₹76.55 |
| Non-Current Liabilities | ₹67.11 | ₹17.93 | ₹19.30 | ₹21.25 |
| Equity Capital | ₹278.71 | ₹141.40 | ₹121.47 | ₹96.38 |
| Total Equity & Liabilities | ₹642.14 | ₹486.65 | ₹307.60 | ₹257.28 |
About Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, Nutraceuticals, Cosmeceuticals and Mobility. Its Generics Division, marketed under the Fredun Gx brand. The Pet Healthcare segment operates under the Freossi brand. The Nutraceutical Division under Fredun Nutrition brand. Its Cosmeceuticals Division, operating under the Bird N Beauty (BNB) and Beautyfred brands, is focused on skincare and personal care products. Its Mobility Division, operating under Chuu Balm, BraceOn, NebOn, and DigiOn, caters to the ortho rehabilitation aids and pain management market. It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It also provides comprehensive pet care technology platforms.
Fredun Pharmaceuticals Limited Financial Highlights
- Revenue: Fredun Pharmaceuticals Limited reported revenue of ₹639.12 crore in FY26 vs ₹456.27 crore in FY25. It showed an increase of 40.07% on a yearly basis.
- Operating Profit: Fredun Pharmaceuticals Limited reported an operating profit of ₹47.00 crore in FY26 vs ₹27.49 crore in FY25. It showed an increase of 70.97% on a year-on-year basis.
- Net Profit: Fredun Pharmaceuticals Limited reported a net profit of ₹32.62 crore in FY26 vs ₹19.74 crore in FY25. It showed an increase of 65.25% on a yearly basis.
Fredun Pharmaceuticals Limited Quarterly Result Highlights
- Fredun Pharmaceuticals Limited reported revenue of ₹213.06 crore in Mar 2026, compared with ₹160.92 crore in Dec 2025, representing an increase of 32.40% on a quarter-on-quarter (QoQ) basis.
- Fredun Pharmaceuticals Limited reported an operating profit of ₹11.25 crore in Mar 2026, compared with ₹14.00 crore in Dec 2025, representing a decrease of 19.64% on a quarter-on-quarter (QoQ) basis.
- Fredun Pharmaceuticals Limited reported a profit of ₹10.78 crore in Mar 2026, compared with ₹10.48 crore in Dec 2025, reflecting an increase of 2.86% on a QoQ basis.
- The earnings per share (EPS) of Fredun Pharmaceuticals Limited stood at ₹66.81 during Mar 2026.
Similar Stocks
FAQs on Fredun Pharmaceuticals Limited Share Price
What is Fredun Pharmaceuticals Limited share price today?
Fredun Pharmaceuticals Limited share price is ₹2,588.80 as on 03 Jul, 2026, 15:53 IST.
How has the Fredun Pharmaceuticals Limited share price performed in the past?
In the last 1 year, Fredun Pharmaceuticals Limited delivered a return of 218.05%. The Fredun Pharmaceuticals Limited share price hit a high of ₹2,891.00 and low of ₹794.00.
How much is the Mutual Fund shareholding in Fredun Pharmaceuticals Limited shares?
The Mutual Fund Shareholding in Fredun Pharmaceuticals Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Fredun Pharmaceuticals Limited shares ?
The 52-week high and low of Fredun Pharmaceuticals Limited share is ₹2,891.00 and ₹794.00 as of 03 Jul, 2026.
What is the market cap of Fredun Pharmaceuticals Limited?
The market capitalisation of Fredun Pharmaceuticals Limited is ₹1,520.84 Crores as on 03 Jul, 2026.
What are the stock symbols of Fredun Pharmaceuticals Limited?
The stock symbol of Fredun Pharmaceuticals Limited is 539730 on the BSE, and the ISIN is INE194R01017.
What was yesterday's closing price for Fredun Pharmaceuticals Limited shares ?
Fredun Pharmaceuticals Limited shares closed yesterday at ₹2,758.80 on BSE
How to buy Fredun Pharmaceuticals Limited shares?
To buy Fredun Pharmaceuticals Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Fredun Pharmaceuticals Limited shares on Holidays?
No, shares of Fredun Pharmaceuticals Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Fredun Pharmaceuticals Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Fredun Pharmaceuticals Limited?
The PE and PB ratio of Fredun Pharmaceuticals Limited is 28.05 and 3.46 respectively, as on 03 Jul, 2026, 15:53 IST.